Stocks on Thursday finished down the most since June, in marked contrast to the recent record-breaking results, as investors moved out of the tech sector.
Nevertheless, some stocks were climbing. Here are some of the top gainers for Thursday:
1. Macy's | Percentage Increase Over 7%
Shares of Macy's (M) - Get Macy's Inc Report climbed after the retailer on Wednesday reported a narrower-than-expected second-quarter loss and better-than-forecast same-store sales amid a rebound in consumers’ appetite for clothing and accessories, particularly online. Same-store sales fell 34.7%, nearly twice the 18.7% drop analysts had been expecting. However, that was offset by a 53% gain in digital sales.
2. Sutro Biopharma | Percentage Increase Over 15%
Sutro Biopharma (STRO) - Get Sutro Biopharma, Inc. Report shares rose after the company said its ongoing Phase I dose-escalation trial of STRO-002 in ovarian and endometrial cancer demonstrated promising efficacy and safety profile in a heavily pretreated patient population not selected based on receptor expression.
3. Carnival Corp. CCL | Percentage Increase Over 5%
Carnival Corp. (CCL) - Get Carnival Corporation Report advanced as the cruise ship operator plans to resume cruises out of Italy on Sunday. Passenger cruises have been suspended since mid-March because of the coronavirus pandemic shutdown. Carnival also plans to have its Germany-based AIDA Cruises resume sailings on Nov. 1. Carnival's stock has tumbled 65% year to date.
4. John Wiley & Sons | Percentage Increase Over 5%
John Wiley & Sons (JWA) rose after the publishing and research company beat Wall Street's first-quarter earnings expectations. Brian Napack, president and CEO, said Wiley's strategies in open research and online education "are paying off with unprecedented gains in Research article output and content consumption, strong online enrollment growth, and record new adoption of digital courseware."
5. Five Below | Percentage Increase Over 8%
Five Below (FIVE) - Get Five Below, Inc. Report climbed after the after the specialty value retailer’s second-quarter revenue of $426.1 million beat analysts’ expectations of $405.8 million. Quarterly sales improved by 2.1% over a year ago, driven mostly by the gradual reopening of stores. The company reported earnings of 53 cents a share, more than triple Wall Street's call for 14 cents, and up from 51 cents per share a year earlier.